American specialty pharmaceutical company at Hayward in California, founded in 1999 and listed on Nasdaq until it combined with Amneal Pharmaceuticals in 2018. Ran a generics division making controlled release and other difficult to copy generic medicines and a branded division, Impax Specialty Pharma, selling central nervous system products including Rytary for Parkinson's disease and Zomig for migraine, with plants in California, Pennsylvania and Taiwan and its own formulation and analytical development.
No hay comentarios disponibles.
Deja tu valoración & comentario